Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Compass Pathways (NASDAQ:CMPS) Announces Earnings Results, Misses ...
Compass Pathways to Announce Second Quarter and First Half 2026 ...
B. Riley Financial Issues Positive Forecast for Compass Pathways ...
COMPASS Pathways ADS Q2 2026 earnings preview
Compass Pathways Announces Second Quarter and First Half 2026 Financial ...
Compass Pathways Clears Another Hurdle – Builds Stronger FDA Case For ...
Compass Pathfinder Limited: Compass Pathways Announces Second Quarter ...
Compass Pathways Announces 2025 Financial Results and Highlights ...
Compass Pathways Stock Forecast - SCIENCE EDUCATION
Compass Pathways Announces Third Quarter 2025 Financial Results and ...
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial ...
Compass Pathways (CMPS) Stock: Surges as FDA Grants Priority Voucher ...
Compass Pathfinder Limited: Compass Pathways to Participate in ...
COMPASS Pathways Announces Up to $285 Million Private Placement ...
Compass Pathways - Compass Pathways Announces Second Quarter and First ...
Compass Pathways Announces U.S Grant Program for the Creation of Post ...
Compass Pathways shares rise on Q1 results, accelerated FDA review
Compass Pathways Q2 2026 Earnings Review - Finsee
Compass Pathways Q2 Earnings Call Highlights
Compass Pathways Announces Pricing of $150 Million Public Offering
Compass Pathways 2026年第二季度财报：权证估值损失放大净亏损
Compass Pathways Plc Aktie: Pakt mit US-Veteranenbehörde
Compass Pathways Aktie: Kassenpolster bis 2028
Compass Pathways establishes research collaboration with Mindful Health ...
Compass Pathways to announce fourth quarter and year-end 2023 financial ...
Compass Pathways - Compass Pathways announces durable improvement in ...
Press Releases about COMPASS Pathways Plc - American Depository Shares ...
CMPS | COMPASS Pathways PLC ADR Stock Overview (U.S.: Nasdaq) | Barron's
Compass Pathways Aktie: Zahlen vor Zulassung
Mental Health Care Company COMPASS Pathways Concludes Successful Series ...
Compass Pathways Announces Pricing of $150 Million Public Offering ...
London's COMPASS Pathways gets $285M funding boost to advance ...
Compass Pathways PLC: A Psychedelic Trip Worth Taking? - Sick Economics
Invest in Psilocybin Therapy with Compass Pathways Stock - Nanalyze
Compass Pathways Rises 10% After Positive Phase 3 Results for COMP360 ...
Compass Pathways CMPS Psilocybin FDA Approval — What You Need to Know ...
Compass Pathways reports strong Q1 results, shares surge
Compass Pathways | LinkedIn
COMPASS Pathways Careers | Levels.fyi
Compass Pathways Study Finds SSRI Drugs Did Not Impede Psilocybin's ...
How Compass Pathways Pulled Forward a Psilocybin Launch by Nearly a Year
COMPASS Pathways Is Trying to Patent Psilocybin for More Mental Health ...
Compass Pathways drops despite hitting primary goal in psilocybin trial ...
COMPASS Pathways Teams with UK Institutions to Research Innovations in ...
Compass Pathways launching NEW Phase II Clinical Trial to Treat PTSD ...
COMPASS Pathways Stock Rallies 50% Following Trump Executive Order on ...
Compass Pathways on LinkedIn: #mentalhealthawarenessweek #mentalhealth ...
Compass Pathways | Biotechnology Company
Compass Pathways Appoints a New CEO | Psychedelic Spotlight
Is Compass Pathways Poised for Success? | Psychedelic Invest
Interview: Compass Pathways CEO Kabir Nath Discusses Commercialisation ...
COMPASS Pathways Readies Itself for the Psychedelic Medicine Revolution ...
Compass Pathways Delivers Better-Than-Expected Q3 As Therapy Launch ...
MindMed Surpasses Compass Pathways As Largest Publicly Traded ...
COMPASS Pathways Financial Analysis: Road to Profitability ...
Compass Pathways Stock Extends Gains on New Patent for Psilocybin ...
Compass Pathways Lost Its Co-Founders - Now What? | Psychedelic Invest
Compass Pathways – World Social Media Awards
Compass Pathways Shares Surge as Analysts Boost Price Targets - Stocks ...
Compass Pathways — Navigating the System with You
Compass Pathways Reports COMP360 Progress - The Dales Report
Taking a Look at Compass Pathways | A Synthetic Psilocybin Company ...
Compass Pathways partners with Osmind on clinic readiness | CMPS Stock News
Compass Pathways is threatening to create a magic mushroom monopoly
Magic Mushroom Compass Pathways (CMPS) IPO Valued at Near $1 Billion ...
Compass Pathways Reveals Results of Psilocybin Study - Legal Reader
How to Buy Compass Pathways Stock [2026] | Invest in CMPS
Compass Pathways Phase 3 Results Raise Hopes For FDA Approval Of Psilocybin
Compass Pathways PLC 8-K Report: Key Announcements for January 2025 ...
Compass Pathways Releases Promising New Data from Landmark Psilocybin ...
Compass Pathways Goes On Bad Trip, Despite 'Positive' Results From ...
Compass Pathways Achieves Breakthrough in Psilocybin Therapy for ...
Compass Pathways: The Psilocybin Biotech Leader With Strong Momentum ...
Stock Movers: QXO, Compass Pathways, Fermi - Bloomberg
Compass Pathways: B.Riley bestätigt Buy-Rating und Kursziel $17 nach M
Singapore COMPASS 2026: Complete Guide for Indian Students and Graduates
Homes for Sale Under $350K in Lamont, WA | Compass
Compass Medical files for bankruptcy: How it affects two new lawsuits
Compass Heading Display V1.1 – FS25.net
Compass Heading Display v1.0 | FS25 Mod Download
Strategic Growth Manager @ Compass | Simplify Jobs
Compass Pathways' Opens Trading at $23.40 – Above Expected Range ...
Compass Pathways: Navigating Mental Health Pathways, all the way to the ...
Compass Pathways: Big Picture Look At Positive Clinical Trials - The ...
COMPASS Pathways' Psilocybin Patent Questioned By UK Patent Examiner
Psychedelics Sector Poised To Soar If Compass Pathway's Chart Breaks ...
Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle - Psychedelic ...
I am thrilled to join the Compass team. I look forward to doing my part ...
Compass Pathways' COMP360 Psilocybin Therapy Shows Promise in Phase 3 ...
Compass Pathways' Psychedelic Trials: A Milestone Moment for the Sector
Atai Life Sciences, Compass Pathways, MindMed & Cybin's Q3 Financial ...
Magic Mushrooms, Hard Cash: Compass Pathways’ Trial Win, Fast Raise
Compass Pathways' Second Psilocybin Win
CMPS Q2 2026 Earnings Report on 8/5/2026
Senior Corporate Counsel, Advertising, Promotion & Market Access ...
CMPS Q4 2025 Earnings Report on 3/24/2026
1707 Southwest Thyme Drive Southwest, Byron Center, MI 49315 | MLS ...
18508 Idlewind Ct, Westfield, IN 46074
1008 E Front St, Plainfield, NJ 07062 | MLS #4045621
CMPS Q4 2024 Earnings Report on 2/27/2025
57 patient pathway coordinator jobs in London, England, August 2026 ...
Psychedelic stocks rally after Trump orders faster PTSD research ...
COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 ...
5 Most Important Psychedelic Clinical Trials in 2022 | Psychedelic ...
